Skystar Bio Pharmaceutical Co. (SKBI) Reports Q2 Earnings of $0.21; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
General and administrative: 1.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
General and administrative: 1.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Skystar Bio Pharmaceutical Co. (NASDAQ: SKBI) reported Q2 EPS of $0.21, versus $0.33 reported last year. Revenue for the quarter came in at $9.1 million, versus $8.26 million reported last year.
Sees FY2011 revenue of $52 to $55 million.
Sees FY2011 revenue of $52 to $55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- Prabhudas Lilladher Starts Aditya Birla Sun Life AMC (ABSLAMC:IN) at Buy (1)
- Gen Digital CEO addresses GoDaddy acquisition rumors
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
